69451 weinheim, germany · yi-lin huang, wei-chung hong, chien-chen lai, yi-hung liu, shie-ming...
TRANSCRIPT
Supporting Information
© Wiley-VCH 2007
69451 Weinheim, Germany
1
Using Acetate Anions to Induce Translational Isomerization in a Neutral
Urea-Based Molecular Switch
Yi-Lin Huang, Wei-Chung Hong, Chien-Chen Lai, Yi-Hung Liu, Shie-Ming Peng, and Sheng-Hsien Chiu*
Data Page Number
Experimental procedures and characterization data for all new compounds ............. S2–S6
Dilution isotherm for macrocycle 1 and urea-based thread 4 in CDCl3....................... S7
Dilution isotherm/Job plot for macrocycle 1 and urea-based thread 3 in CDCl3......... S7–S8
1H and 13C NMR spectra of 2....................................................................................... S9–S10
1H and 13C NMR spectra of macrocycle 1 ................................................................... S11–S12
1H and 13C NMR spectra of 3....................................................................................... S13–S14
1H and 13C NMR spectra of III .................................................................................... S15–S16
1H and 13C NMR spectra of 8....................................................................................... S17–S18
1H and 13C NMR spectra of the [2]rotaxane 9 ............................................................. S19–S20
1H and 13C NMR spectra of V ...................................................................................... S21–S22
1H and 13C NMR spectra of 5....................................................................................... S23–S24
1H and 13C NMR spectra of the [2]rotaxane 6 ............................................................. S25–S26
1H, 13C, 2D COSY, and NOSY NMR spectra of the [2]rotaxane 7.............................. S27–S32
2D COSY and NOSY NMR spectra of the [2]rotaxane 7 + TMAA (5 eq).................. S33–S37
2
General Methods: All glassware, stirrer bars, syringes, and needles were either oven- or
flame-dried prior to use. All reagents, unless otherwise indicated, were obtained from
commercial sources. Anhydrous CH2Cl2 and MeCN were obtained by distillation from
CaH2 under N2. Anhydrous THF was obtained by distillation from Na/Ph2CO under N2.
Reactions were conducted under N2 or Ar atmospheres. Thin-layer chromatography (TLC)
was performed on Merck 0.25 mm silica gel (Merck Art. 5715). Column chromatography
was undertaken over Kieselgel 60 (Merck, 70–230 mesh). Melting points are uncorrected.
In NMR spectra, the deuterated solvent was used as the lock, while either the solvent’s
residual protons or TMS was employed as the internal standard. Chemical shifts are
reported in parts per million (ppm). Mutiplicities are given as s (singlet), d (doublet), t
(triplet), q (quartet), m (mutiplet), and br (broad).
Diethylene glycol 4-cyanobenzyl ether (2): NaH (0.57 g, 14.2 mmol) was added to a DMF
solution (20 mL) of diethylene glycol (0.45 mL, 4.7 mmol) and the solution mixture was
stirred at room temperature for 1 h before added 4-cyanobenzylbromide (2.21 g 11.3 mmol).
The solution mixture was then stirred at room temperature for 16 h and the organic solvent
was evaporated under reduced pressure. The residue was then purified by column
chromatography (SiO2; CH2Cl2/hexanes, 7:3) to give compound 2 as a yellow liquid (1.42 g,
90%). 1H NMR (400 MHz, CDCl3): δ = 3.63−3.68 (m, 8H), 4.58 (s, 4H), 7.40 (d, J = 8.4
Hz, 4H), 7.56 (d, J = 8.4 Hz, 4H); 13C NMR (100 MHz, CDCl3): δ = 70.0, 70.5, 72.1, 110.8,
118.4, 127.2, 131.6, 143.3. HRMS (ESI): m/z calcd for [M + H]+ C20H21N2O3 337.1552, found
337.1559.
Macrocycle 1: LiAlH4 (0.40 g, 10.5 mmol) was added to a THF solution (40 mL) of 2 (0.56 g,
1.7 mmol) and the solution mixture was heated under reflux for 4 h. After cooled to room
temperature, the reaction was quenched by slowly added water. The precipitation was then
filtered off, and the filtrate was dried (MgSO4) and concentrated to yield the desired diamine
as a light yellow oil (0.40 g, 70%). The crude diamine was dissolved in methanol and
methyl 2,6-pyridine dicarboxylate (0.22 g, 1.1 mmol) was added. The solution mixture was
then stirred at 50 °C for 6 d and the organic solvent was evaporated under reduced pressure.
The residue was then purified by column chromatography (SiO2; CH2Cl2/methanol, 99:1) to
3
give macrocycle 1 as a white solid (0.11 g, 20%). m.p. 241−242 °C; 1H NMR (400 MHz,
CDCl3): δ = 3.70 (m, 8H), 4.57 (s, 4H), 4.63 (d, J = 5.2 Hz, 4H), 7.22 (d, J = 7.6 Hz, 4H),
7.29 (d, J = 7.6 Hz, 4H), 7.94 (br, 2H), 8.02 (t, J = 8 Hz, 1H), 8.30 (d, J = 8 Hz, 2H); 13C
NMR (100 MHz, CDCl3): δ = 43.4, 69.7, 70.9, 72.8, 124.7, 127.0, 127.8, 136.5, 137.3,
139.0, 147.9, 162.7; HRMS (ESI): m/z calcd for [M]+ C27H29N3O5 475.2107, found 475.2129.
NH2O1. Triphosgene / Et3N
2. II
O
3
ON N
O
HH
1,3-Bis(4-(hexyloxy)phenyl)urea (3): A solution of triethylamine (0.66 mL, 4.7 mmol) and
4-hexyloxyaniline (I; 0.4 g, 2.07 mmol) in benzene (25 mL) was added to a solution of
triphosgene (0.31 g, 1.05 mmol) in benzene (25 mL). The mixture was stirred at room
temperature for 6 h, filtered, and then concentrated under reduced pressure. The resulting
isocyanate was dissolved in acetone (5 mL); 4-hexyloxyaniline (0.4 g, 2.07 mmol) was added
and the mixture stirred at room temperature for 2 h. The solvent was evaporated under
reduced pressure and the residue recrystallized from ethyl alcohol to afford 3 as a white solid
(0.48 g, 56% for two steps). M.p. 184.1−184.6 °C; 1H NMR (400 MHz, CD3SOCD3): δ =
0.88 (t, J = 6.4 Hz, 6H), 1.22−1.41 (m, 12H), 1.68 (quint, J = 6.4 Hz, 4H), 3.89 (t, J = 6.4 Hz,
4H), 6.82 (d, J = 9.2 Hz, 4H), 7.30 (d, J = 9.2 Hz, 4H), 8.33 (br, 2H); 13C NMR (100 MHz,
CD3SOCD3): δ = 14.0, 22.2, 25.3, 28.8, 31.1, 67.5, 114.4, 119.7, 132.6, 152.7, 153.5;
HRMS (ESI): m/z calcd for [M + H]+ C25H37N2O3 413.2799, found 413.2804.
O
HN
HN
O OHSi
8
NH2
OSi
NH2
OH
TIPSCl
1. Triphosgene / Et3N
2. II
II
III
4-(Triisopropylsilyloxymethyl)aniline (III): A solution of 4-aminobenzyl alcohol (II; 2 g,
16 mmol) in DMF (40 mL) was treated with imidazole (1.06 g, 16 mmol) and TIPSCl (3.4
mL, 16 mmol). The resulting solution was stirred at room temperature for 12 h, diluted with
EtOAc (200 mL), washed with brine, dried (MgSO4), and concentrated. The residue was
4
purified through chromatography (SiO2; EA/Hex, 1:4) to afford compound III as a clear oil
(3.8 g, 84%). 1H NMR (400 MHz, CDCl3): δ = 1.08−1.22 (m, 21 H), 3.59 (br, 2H), 4.70 (s,
2H), 6.64 (d, J = 8.4 Hz, 2H), 7.13 (d, J = 8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3): δ =
12.4, 18.4, 64.9, 114.5, 126.7, 131.1, 144.6; HRMS (ESI): m/z calcd for [M + H]+
C16H30NOSi 280.2091, found 280.2097.
8: Triphosgene (0.28 g, 0.94 mmol), triethylamine (0.6 mL, 4.3 mmol) and III (0.5 g, 1.79
mmol) were added to benzene (50 mL) and then stirred at room temperature for 6 h. The
resulting suspension was filtered and the solvent evaporated under reduced pressure. The
crude isocyanate was dissolved in acetone (5 mL); 4-aminobenzyl alcohol (II) (0.5 g, 4.05
mmol) was added and the mixture stirred at room temperature for 2 h. The solution was
concentrated and the residue purified through chromatography (SiO2; EA/Hex, 1:1) to afford
compound 8 as a white solid (0.4 g, 52%). M.p. 158−159 °C; 1H NMR (400 MHz, CDCl3):
δ = 1.10−1.20 (m, 21H), 4.33 (s, 2H), 4.70 (s, 2H), 6.94 (m, 4H), 7.17 (m, 4H), 7.61 (s, 1H),
7.70 (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 12.5, 18.5, 64.4, 64.8, 119.9, 120.3, 126.1,
127.3, 135.2, 136.3, 136.5, 137.0, 153.7; HRMS (ESI): m/z calcd for [M + Na]+
C24H36N2NaO3Si 451.2387, found 451.2393.
O
HN
HN
O
5
OH
O
HN
HN
OH
NH2
1. Triphosgene / Et3N
2. H2N
OH
Br OH
IV
V
K2CO3
1-(3,5-Di-tert-butylphenyl)-3-(4-hydroxyphenyl)urea (V): Triphosgene (0.36 g, 1.22 mmol),
triethylamine (0.8 mL, 5.69 mmol), and 3,5-di-tert-butylaniline (IV) (0.5 g, 2.43 mmol) were
added to benzene (70 mL) and the mixture stirred at room temperature for 6 h. The resulting
suspension was filtered off and the solvent evaporated under reduced pressure. The resulting
isocyanate was dissolved in acetone (5 mL); 4-aminobenzyl alcohol (0.5 g, 4.05 mmol) was
added and the mixture stirred at room temperature for 2 h. The solution was concentrated
and the residue purified through chromatography (SiO2; EA/Hex, 1:2) to afford V as a white
5
solid (0.8 g, 97%). M.p. 238.1–238.8 °C; 1H NMR (400 MHz, CD3SOCD3): δ = 1.27 (s,
18H), 6.67 (d, J = 8.8 Hz, 2H), 6.98 (s, 1H), 7.2 (d, J = 8.8 Hz, 2H), 7.26 (s, 1H), 8.2 (s, 1H),
8.43 (s, 1H), 9.05 (s, 1H); 13C NMR (100 MHz, CD3SOCD3): δ =31.3, 34.6, 112.4, 115.0,
115.2, 120.3, 131.0, 139.1, 150.4, 152.2, 152.7; HRMS (ESI): m/z calcd for [M + H]+
C21H29N2O2 341.2224, found 341.2229.
5: K2CO3 (3.25 g, 23.5 mmole) and 5-bromo-1-pentanol (0.43 ml, 3.2 mmol) were added to a
DMF (25 mL) solution of V (0.8 g, 2.35 mmol). The resulting mixture was stirred at 90 °C
for 12 h, filtered, and concentrated under reduced pressure. The residue was then partitioned
between CH2Cl2 (25 mL) and H2O (25 mL) and the organic solution was dried (MgSO4) and
concentrated. The crude product was then purified through chromatography (SiO2; EA/Hex,
1:1) to afford 5 as a white solid (0.52 g, 52%). M.p. 197.8−198.3 °C; 1H NMR (400 MHz,
CDCl3): δ = 1.26 (s, 18H), 1.51 (quint, J = 6.8 Hz, 2H), 1.62 (quint, J = 6.8 Hz, 2H), 1.77
(quint, J = 6.8 Hz, 2H), 3.65 (br, 2H), 3.88 (t, J = 6.8 Hz, 2H), 6.76−6.88 (m, 4H), 7.13−7.20
(m, 5H); 13C NMR (100 MHz, CD3SOCD3): δ = 22.3, 29.0, 31.4, 32.4, 34.9, 62.7, 68.1,
115.1, 115.9, 118.4, 123.7, 130.7, 137.4, 152.0, 154.3, 156.1; HRMS (ESI): m/z calcd for [M
+ Na]+ C26H38N2NaO3 449.2775, found 449.2780.
Rotaxane 6: Di-n-butyl dilaurate (0.03 mL, 0.045 mmol) was added to a CH2Cl2 solution (3
mL) of 5 (0.13 g, 0.3 mmol), macrocycle 1 (0.17 g, 0.36 mmol), and 4-triphenylmethylphenyl
isocyanate (0.13 g, 0.36). After the mixture had been stirred at room temperature for 24 h,
the precipitate was filtered off and the organic solution concentrated under reduced pressure.
The residue was purified by chromatography (SiO2; CH2Cl2/MeOH, 99:1) to afford rotaxane 6
as a white solid (85 mg, 23%). M.p. 126−127 °C; 1H NMR (400 MHz, CDCl3): δ = 1.27
(s, 18H), 1.53 (quint, J = 6.2 Hz, 2H), 1.63–1.80 (m, 4H), 3.52–3.65 (m, 4H), 3.68–3.73 (m,
4H), 3.82 (t, J = 6.2 Hz, 2H), 4.07–4.20 (m, 4H), 4.31 (s, 4H), 4.58–4.66 (m, 2H), 6.32 (br,
2H), 6.47 (d, J = 8.8 Hz, 2H), 6.78 (d, J = 8 Hz, 4H), 6.83 (d, J = 8 Hz, 4H), 6.90 (d, J = 8.8
Hz, 2H), 7.01 (s, 1H), 7.02 (s, 2H), 7.07–7.29 (m, 20H), 8.04 (t, J = 8 Hz, 1H), 8.43 (d, J = 8
Hz, 2H), 9.45 (br, 2H); 13C NMR (100 MHz, CDCl3): δ = 22.7, 28.8, 29.1, 31.5, 34.9, 43.7,
64.4, 65.0, 67.8, 68.4, 70.6, 73.8, 112.6, 113.9, 115.4, 117.4, 119.2, 125.0, 125.7, 127.3, 128.0,
128.9, 130.9, 131.5, 132.2, 134.9, 135.7, 137.1, 138.2, 138.6, 141.4, 146.6, 149.3, 150.7,
152.1, 153.5, 153.7, 164.0; HRMS (ESI): m/z calcd for [M + Na]+ C79H86N6NaO9 1285.6348,
found 1285.6354.
6
Rotaxane 7: Di-n-butyl dilaurate (0.02 mL, 0.03 mmol) was added to a CH2Cl2 (2 mL)
solution of 5 (92 mg, 0.22 mmol), macrocycle 1 (0.1 g, 0.21 mmol), and
3,5-di-tert-butylphenyl isocyanate (0.13 g, 0.36 mmol). After the mixture had been stirred at
room temperature for 24 h, the precipitate was filtered off and the organic solution
concentrated under reduced pressure. The residue was purified through chromatography
(SiO2; EA/Hex, 1:1) to afford rotaxane 7 as a white solid (48 mg, 20%). M.p. 100−101 °C; 1H NMR (400 MHz, CDCl3): δ = 1.27 (s, 18H), 1.30 (s, 18H), 1.56 (quint, J = 6.4 Hz, 2H),
1.70–1.82 (m, 4H), 3.56–3.68 (m, 4H), 3.71–3.74 (m, 4H), 3.84 (t, J = 6.4 Hz, 2H), 4.13–4.21
(m, 4H), 4.31 (s, 4H), 4.58–4.65 (m, 2H), 6.33 (s, 1H), 6.35 (s, 1H), 6.48 (d, J = 8.6 Hz, 2H),
6.78 (d, J = 8 Hz, 4H), 6.83 (d, J = 8 Hz, 4H), 6.90 (d, J = 8.6 Hz, 2H), 7.00 (s, 1H), 7.01 (s,
2H), 7.11 (s, 1H), 7.22–7.25 (br, 3H), 8.06 (t, J = 8 Hz, 1H), 8.43 (d, J = 8 Hz, 2H), 9.51 (br,
2H); 13C NMR (100 MHz, CDCl3): δ = 22.7, 28.9, 29.1, 31.4, 31.5, 34.9, 35.0, 43.7, 64.9,
67.8, 68.4, 70.6, 73.8, 112.5, 113.2, 113.9, 115.3, 117.3, 119.0, 124.9, 128.0, 128.9, 132.2,
134.8, 137.0, 137.2, 138.2, 138.6, 149.3, 150.6, 151.3, 152.0, 153.6, 164.1 (one signal is
missing, possibly because of signal overlapping); HRMS (ESI): m/z calcd for [M + Na]+
C68H88N6NaO9 1155.6505, found1155.6510.
Rotaxane 9: Triethylamine (0.1 mL, 0.71 mmol) and triisopropylsilyl triflate (0.2 mL, 0.74
ml) were added dropwise to a solution of the urea-derived thread 8 (0.27 g, 0.63 mmol) and
macrocycle 1 (0.3 g, 0.63 mmol) in CH2Cl2 (6 mL). The mixture was stirred at room
temperature for 12 h and the solvent evaporated under reduced pressure. The residue was
purified through chromatography (SiO2; EA/Hex, 1:2) to afford rotaxane 9 as a colorless oil
(80 mg, 12%). 1H NMR (400 MHz, CDCl3): δ = 1.00−1.20 (m, 42H), 3.55−3.62 (m, 4H),
3.70−3.75 (m, 4H), 4.32 (s, 4H), 4.47 (d, J = 5.6 Hz, 4H), 4.70 (s, 4H), 6.55 (s, 2H), 6.74 (d, J
= 7.6 Hz, 4H), 6.80 (d, J = 7.6 Hz, 4H), 6.94 (d, J = 8.4 Hz, 4H), 7.00 (d, J = 8.4 Hz, 4H),
8.08 (t, J = 8 Hz, 1H), 8.44 (d, J = 8 Hz, 2H), 9.39 ( br, 2H); 13C NMR (100 MHz, CDCl3):
δ = 12.5, 18.5, 43.7, 64.8, 68.7, 70.6, 74.0, 117.0, 124.7, 125.5, 127.8, 128.6, 134.3, 134.4,
137.1, 137.5, 138.0, 148.9, 151.3, 163.3; HRMS (ESI): m/z calcd for [M + Na]+
C60H85N5NaO8Si2 1082.5829, found 1082. 5834.
7
The Complexation of Macrocycle 1 and Thread 3 in CDCl3 Dilution Isotherm
0.0010 0.0015 0.0020 0.0025 0.0030 0.0035 0.0040 0.0045
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
Data: Data1_BModel: nmr 1:1 dilution Chi^2 = 5.9784E-6R^2 = 0.98889 K 177.14348 ±20.26132D 0.32883 ±0.02231
Che
mic
al S
hift
Diff
eren
ce (∆
δ)
Concentration (M)
Using the signal of free 1 at δ 4.554 as the reference
The Complexation of Macrocycle 1 and Thread 4 in CDCl3 Dilution Isotherm
0.0002 0.0004 0.0006 0.0008 0.00100.11
0.12
0.13
0.14
0.15
0.16
0.17
Data: Data1_BModel: nmr 1:1 dilution Chi^2 = 1.5063E-6R^2 = 0.99474 K 10568.07044 ±481.14205D 0.22268 ±0.00228
Che
mic
al s
hift
diffe
renc
e (∆
δ)
Concentration (M)
B
Using the signal of free 1 at δ 4.554 as the reference
8
The Complexation of Macrocycle 1 and thread 3 in CDCl3
Job Plot
0 0.2 0.4 0.6 0.8 1
0.01
0.02
0.03
[1]/{[1]+[3]}
∆δx
[1]/{
[1]+
[3]}
([1]+[3]) = 5.0 mM
Using the signal of free 1 at δ 4.554 as the reference
2
S9
2
S10
1
S11
1
S12
S13
3
S14
3
S15
III
S16
III
S17
8
S18
8
S19
9
S20
9
S21
V
S22
V
S23
5
S24
5
S25
6
S26
6
7
S27
7
S28
S29
NHN
NH
O
O
OO
O
ON
NH
H
OO
O
H NHe'
Ha'
Hb'
Hi'
Hj'
Hc' Hd'
Hf'Hh'
Hg'
Hk'
Hl'
Hi''
Hj''
Hh'
Hc'
+ H
d'
Hg'
Hj'
+Hi''
Hj''
Hb' H
a'
Hk'
Hl'
He'H
f'
Hm
'+H
m''
OC
H2C
H2O
NN
O
H
N H
O
N H
N HO
OC
H2
Hi'
C(Hm''3)
(Hm'3)C
S30
N HNNH
O
O
OO
O
ON
NHH
O O
O
HNHe'
Ha' Hb'
Hi'Hj'
Hc'
Hd'
Hf'
Hh'Hg'
Hk' Hl'
Hi''
Hj''
Hc' + Hd'
Hj'
Hh'Hg'N
N
O
H
NH
O
NH
Hh'
N
NO
H
H
Hj''
NH
O
O
Partial 2D NOSY [500 MHz, CDCl3/CD3CN (1:1), 298K]
S31
N HNNH
O
O
OO
O
ON
NHH
O O
O
HNHe'
Ha' Hb'
Hi'Hj'
Hc'
Hd'
Hf'
Hh'Hg'
Hk' Hl'
Hi''
Hj''
NN
O
H
Hc' + Hd'
NH
O
O
Hh'
Hj'
NH
O
NH
Hj''Hg'
He'Hf'
Hh'
Hk'
CH2
OCH2CH2O
Hl'
2D NOSY [500 MHz, CDCl3/CD3CN (1:1), 298K]
S32
2D COSY (400 MHz, CD3CN/CDCl3 (1:1), 298 K)
N HNNH
O
O
OO
O
ON
NHH
O O
O
HNHe'
Ha' Hb'
Hi'Hj'
Hc'
Hd'
Hf'
Hh'Hg'
Hk' Hl'
Hi''
Hj''
NN
O
H
He'
Hk'Hl'
Hg'
Hh'
S33
Hb'
Ha'
Hg'
+Hj' Hj''
Hi''
Hi'
Hc'
+ H
d'
Hh'
He'
Hf'
Hl'
Hm
''H
m'
OC
H2C
H2O
CH
2
NN
O
H
N HN
NH
O
O
OO
O
He'
Hf'
Hc'
Hd'
Ha'
Hb'
O
ON
C(H
m'') 3
Hi''
H
O
N
O
N(H
m') 3
CH
k'H
h'
Hg'
Hj'
Hi'
CH
3 OO H
H
Hl'
Hj''
S34
Partial 2D NOSY (500 MHz, CD3CN/CDCl3 (1:1), 298 K)
Hj''
Hh'
Hg' +Hj'
Hc' + Hd'NN
O
H
N
HNNH
O
O
OO
O
He'
Hf'
Hc'Hd'
Ha'Hb'
O
ON C(Hm'')3
Hi''
H
O
N
O
N(Hm')3C
Hk'Hh'
Hg'Hj'
Hi'
CH3
OO
H H
Hl'Hj''
S35
Partial 2D NOSY (500 MHz, CD3CN/CDCl3 (1:1), 298 K)
Hm''
Hm'
Hi''
Hi'
Hg'+Hj'
Hc' + Hd'Hj''
Hh'
Hk'
N
HNNH
O
O
OO
O
He'
Hf'
Hc'Hd'
Ha'Hb'
O
ON C(Hm'')3
Hi''
H
O
N
O
N(Hm')3C
Hk'Hh'
Hg'Hj'
Hi'
CH3
OO
H H
Hl'
Hl'OCH2CH2O
Hf'
Hj''
S36
2D NOSY (500 MHz, CD3CN/CDCl3 (1:1), 298 K)
N
HNNH1
O
O
OO
O
He'
Hf'
Hc'Hd'
Ha'Hb'
OO
N
Hi''
H
O
N
O
N Hk'Hh'
Hg'Hj'
Hi'
CH3
OO
H H
NN
O
H
Hb'
Ha'
Hc' + Hd'Hg'+Hj'Hj''
Hi''
Hi'
Hh'
Hm'
Hm'
Hf'He'
Hk'
Hl'
OCH2CH2O
Hk'
CH2
(CHm''3)
(CHm'3)
S37
2D COSY (500 MHz, CD3CN/CDCl3 (1:1), 298 K)
N
HNNH1
O
O
OO
O
He'
Hf'
Hc'Hd'
Ha'Hb'
OO
N
Hi''
H
O
N
O
N Hk'Hh'
Hg'Hj'
Hi'
CH3
OO
H H
NN
O
HCH2
Hk'
Hl'
He'
Hh'
Hg' + Hj'